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Abstract
Purpose – In order to create sustainable health systems, many countries are introducing ways to prioritise
health services underpinned by a process of health technology assessment. While this approach requires
technical judgements of clinical effectiveness and cost effectiveness, these are embedded in a wider set of
social (societal) value judgements, including fairness, responsiveness to need, non-discrimination and
obligations of accountability and transparency. Implementing controversial decisions faces legal, political and
public challenge. To help generate acceptance for the need for health prioritisation and the resulting decisions,
the purpose of this paper is to develop a novel way of encouraging key stakeholders, especially patients and
the public, to become involved in the prioritisation process.
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Design/methodology/approach – Through a multidisciplinary collaboration involving a series of
international workshops, ethical and political theory (including accountability for reasonableness) have been
applied to develop a practical way forward through the creation of a values framework. The authors have
tested this framework in England and in New Zealand using a mixed-methods approach.
Findings – A social values framework that consists of content and process values has been developed and
converted into an online decision-making audit tool.
Research limitations/implications – The authors have developed an easy to use method to help
stakeholders (including the public) to understand the need for prioritisation of health services and to
encourage their involvement. It provides a pragmatic way of harmonising different perspectives aimed at
maximising health experience.
Practical implications – All health care systems are facing increasing demands within finite resources.
Although many countries are introducing ways to prioritise health services, the decisions often
face legal, political, commercial and ethical challenge. The research will help health systems to respond to
these challenges.
Social implications – This study helps in increasing public involvement in complex health challenges.
Originality/value – No other groups have used this combination of approaches to address this issue.
Keywords New Zealand, Evidence-based practice, Hospital management, Inequality, Health services sector,
National Health Service
Paper type Research paper
All health care systems are facing ever greater demands due to aging populations and
increasing opportunities to intervene within finite resources. In order to create effective, fair
and sustainable health systems many countries are introducing ways to prioritise health
services which involves making difficult decisions concerning who gets (and who does not
get) health care interventions. Priority setting requires technical judgements of clinical
effectiveness (what works) and cost effectiveness (is it worth the money). But these
judgements are embedded in a wider set of social (societal) value judgements that underlie
justifiable reasoning about priorities, including fairness, responsiveness to need and
non-discrimination, and obligations of accountability and transparency. Even when these
decisions are based on the best available evidence generated by technically sound health
technology assessment (HTA) programmes they frequently face legal, political,
methodological, philosophical, commercial and ethical challenges. One author’s
experiences as the founding Clinical and Public Health Director of the National Institute
for Health and Care Excellence (NICE) 1999–2012 in the UK (responsible for priority setting
within a HTA framework) has reinforced his view that there is a need to undertake more
research in how to develop approaches to include social values into the prioritisation process
that were conceptually clear and, most importantly, easy to apply on a routine basis in a
consistent manner. This is necessary to reassure patients and the public that institutions
making tough prioritisations decisions on their behalf were doing so in an acceptable robust
manner and reflected societal values. Stimulating stakeholder involvement, especially public
participation, is considered key to making difficult decisions acceptable to the public and
professionals as well as fulfilling the moral obligation to make the process as democratic as
possible. It will only happen if the public see the relevance of their contribution, how their
input is to be achieved and the output assessed.
This paper describes a multidisciplinary research programme over the last seven
years that has addressed the twin-related challenges of how to reflect societal values in
health prioritisation and how to encourage the public to understand the need for health
prioritisation and to get involved in these difficult decisions.
A new approach based on the application of social (societal) values
Over the last seven years, an international collaboration of ethicists, philosophers, political
scientists, public health practitioners, lawyers, health economists and health technologists





































This has been carried out through regular multidisciplinary group meetings in London and
a series of international workshops applying mixed methods. In 2011, the inaugural
workshop was convened at Gresham College London to initiate the process by exploring
how social values were currently being incorporated into decision-making processes in
different countries. This event was supported by the Wellcome Trust and the Nuffield
Trust. Representatives from Germany, France, South Korea, the USA, China, World Bank
and South America attended the event. The debate was informed by a working document on
social values prepared by Professor Albert Weale (Weale and Clark, 2012) and each delegate
described how social values were applied to prioritisation processes in their country
according to the framework. The underlying ethical issues relevant to a framework
approach were fully explored and enhanced the view that both content and process values
were important (Biron et al., 2012).
A social values framework
A social values framework emerged from the deliberations of the workshop that consisted of
both content and process values (Littlejohns, Sharma and Jeong, 2012; Littlejohns, Yeung,
Weale and Clark, 2012; Littlejohns, Weale, Chalkidou, Teerwattananon and Faden, 2012).
The process aspects build upon Daniels’ and Sabin’s theory of accountability for
reasonableness (A4R) (Daniels and Sabin, 2008). A4R emphasises the importance of process
values such as transparency and accountability given that reasonable people might
disagree on the content and the outcome of difficult prioritisation decisions. The new
framework, however, emphasises the importance of addressing content as well as process
values, reflecting a broader ethical view of HTA (Bombard et al., 2011; Abelson et al., 2007)
and aligning itself with a “rights” perspective. It suggests that content values such as
clinical and cost effectiveness, fairness and quality of care are equally important in bringing
about fair prioritisation decisions as process values. Transparency about the process of
making a prioritisation decision is meaningless if it does not provide an indication of the
arguments, criteria and trade-offs that ultimately led to the final outcome. Transparency
may, in some cases, even have the opposite of the intended effect if documents or process
descriptions that are made available in the public domain are too long, or too complex, to be
evaluated by a non-expert audience. Process values provide the lens through which to
evaluate the content of the decision-making process.
Testing the framework and creating a decision-making audit tool (DMAT)
This framework was first tested on three national institutions (Littlejohns, Sharma and
Jeong, 2012; Littlejohns, Yeung, Weale and Clark, 2012; Littlejohns, Weale, Chalkidou,
Teerwattananon and Faden, 2012) which demonstrated that it was possible to interrogate
institutions’ value profiles through publicly available data. The first workshop had
demonstrated that the social values framework could be usefully applied in different
countries: the UK (Littlejohns, Sharma and Jeong, 2012; Littlejohns, Yeung, Weale and
Clark, 2012; Littlejohns, Weale, Chalkidou, Teerwattananon and Faden, 2012), Germany
(Kieslich, 2012), the USA (Keren and Littlejohns, 2012), China (Docherty et al., 2012)
South Korea (Ahn et al., 2012) Australia (Whitty and Littlejohns, 2014), Thailand
(Tantivess et al., 2012) and South America (Cubillos et al., 2012). As part of a National
Institute for Health Research funded research project funded through its Collaboration for
Leadership in Applied Health Research and Care South London programme the framework
was converted into a DMAT (Kieslich and Littlejohns, 2015) in order to facilitate its use in
assessing institutions and collecting data. For each value, a series of questions was
developed to support the review of an institution. The user would then grade how complete












































Before you consider how
best to respect social values
and other criteria of
decision making, you need
first to consider the role
that your organisation (or
the one you are auditing)













equality and diversity and
match resources to
population needs?
On a scale from 1 to 5 how
sure are you that your
organisation has systems






3: undecided, 4: sure,
5: very sure)
Transparency Those who commission





decision making is one way
in which organisations can
assure themselves that
they are not making
decisions on grounds that
are considered unfair or
biased by the
wider public
How clearly does your
organisation offer reasons
for decisions?
When your organisation is
faced with a difficult
decision, has it been open
about the difficulties with
those who will ultimately
be affected
by the decisions?
On a scale from 1 to 5 how
sure are you that your
organisation can
demonstrate that it offers
understandable and
accessible reasons for its
decisions? (1: representing
very unsure, 2: somewhat
unsure, 3: undecided, 4:
sure, 5: very sure)
Accountability Those who commission
health care have a great




formal, involving legal or
financial accountability.
Sometimes it is less formal,
for example, to colleagues
or local media outlets. In all
cases accountability
requires an ability to give
reasons for one’s decisions
Has your organisation




provide an account of the
reasons for its decisions in
a variety of formats so that
those who are less used to
reading long and complex
documents can follow
them?
On a scale from 1 to 5 how
sure are you that your
organisation can





3: undecided, 4: sure,
5: very sure)
Participation Participation of
stakeholders and the wider
public is important because
it adds to the views and
values that are considered
when making decisions.
Enabling different groups,




making ensures that these
Whom does your
organisation include in its
decision-making process
and how?
What is the goal of the
participation method your




are the results of
participation exercises
On a scale from 1 to 5 how
sure are you that your
organisation can
demonstrate that it ensures
participation of relevant















































Description Prompt questions Audit question
different views are heard




how is this communicated
to the participants?
Content values
Effectiveness Effectiveness is a
necessary condition for the
provision of good health
and social care. No one
should allocate resources to
forms of care that do no
good or do harm. However,
knowing what is effective
is not easy, especially in the
absence of evidence in the
form of clinical
effectiveness studies in
some areas of health
care provision
Is there a system in place to
identify the evidence for
the effectiveness of
commissioned services?




How are decisions made in
the absence of evidence
(note: absence of evidence
is not the same as evidence
of ineffectiveness)?
On a scale from 1 to 5 how












“value for money” can be
controversial. For some it
means that there is a risk
that financial
considerations could be put
before patients’ needs. For
others it means that the
needs of all patients, rather
than a few, are considered
and that the best possible
care for the largest number
of patients is secured
Is there a system in place to
identify national guidance
or standards such as NICE
recommendations?
Have you taken steps to
assure that what you are
commissioning is cost
effective?
How are decisions made in
the absence of evidence for
cost effectiveness?
On a scale from 1 to 5 how






unsure, 3: undecided, 4:
sure, 5: very sure)
Fairness Fairness goes by different
names. Some people talk
about equity and others
about human rights. In the
area of health care
prioritisation fairness
relates to the question
whether all those who use
health care services are
treated with equal concern
and respect
How are vulnerable patient
groups identified in your
area and how do you ensure
adequate services for these
groups?
Are services commissioned
only on the basis of need
and not on other
characteristics such as age,
gender, ethnicity or sexual
orientation?
On a scale from 1 to 5 how
sure are you that your
organisation can
demonstrate that it is fair
to all population and
patient groups on whose
behalf it is commissioning
services? (1: representing
very unsure, 2: somewhat
unsure, 3: undecided, 4:
sure, 5: very sure)
Solidarity Solidarity is the principle
that “we are all in it
together”. This value
implies that costs for health
care will be covered
collectively in order to
secure access to health care
for individuals
Are services accessible for
all, e.g. are there
mechanisms in place to
cover travel and other costs
of access?
Does your commissioning
strategy create a situation
in which some people
have to fund elements of
treatments from their own
pockets in ways that are
unduly burdensome?
On a scale from 1 to 5 how
sure are you that your
institutions can
demonstrate that it















































In order to be useful, any decision tool needs to be valid (actually measures what it purports
to) and reliable (consistent over time and between observers). Different types of validity
tests are applied, for example, face validity ascertains that the measure appears to be
assessing the intended construct under review. Stakeholders are well placed to assess
face validity, since they can assess the extent to which the criteria are relevant to
decision making. Although this is not the classic “gold standard” type of validity, it is an
essential component in enlisting motivation of stakeholders. Against this background, a
multi-stakeholder workshop of 40 UK health care managers, health professionals,
commissioners, patients and the public was convened in London to introduce the decision
tool and to apply it to local health prioritisation decisions. In light of their comments, the tool
was revised, replacing the domain of solidarity with quality of care for use in a UK setting.
Workshop participants felt strongly that the value of “solidarity” was not as pertinent in the
English NHS context as what was incorporated by it was already included in the value of
“fairness”. Instead, the participants proposed that “quality of care” needed to be included in
a framework that assesses CCG decision making, not just because of recent national
scandals in poor quality health provision, but also because it reflects what the public,
patients and their carers care about. To assess criterion-related validity (the extent to which
a measure is related to an outcome) the framework is currently being applied to a national
sample of CCGs and we will be triangulating the results with interviews of local
stakeholders and publicly available measures of CCG performance published by the
Department of Health (Kieslich and Littlejohns, 2015). Following this preliminary piloting, it
was decided to convert the DMAT into an interactive online version. This would facilitate
more widespread use of the DMAT and, because data would be automatically captured
(through a digital registration process), provide a mechanism to eventually assess inter
observer reliability. Working with a design company an interactive digital online version
has been developed which consists of a series of questions that will allow internal
and external audit of how an institution is incorporating values into its decision making
(www.priorities4health.com/) (Figure 1).
Finally, the DMAT was piloted in a non-UK setting – New Zealand. The DMAT has been
applied to a selection of key national and district health agencies to ascertain whether the
information required is available and why, while also exploring whether the DMAT tool is
relevant to the New Zealand context and what adjustments may be required. Furthermore,








































an explicit evaluation of a process’ fairness will affect public perception of the decision,
regardless of outcome, for any one individual; and how well public voice/social values are
explicitly included in decision making at present. Consultation with representatives of the
public voice have begun with more extensive work planned, to ascertain: whether they agree
an explicit evaluation of a procedural fairness will affect their perception of a decision
regardless of outcome; how their voices or values could be included in decision making
where it currently is not; and whether they find the DMAT tool criteria sufficient/relevant/
applicable. Stakeholders who saw transparency and engagement with the public as largely
positive reasoned that this was due to the opportunities to gain knowledge, relationship
building and internal improvement. Those stakeholders that perceived it as negative,
however, explained that inclusion could lead to bad press (e.g. a group disadvantaged by a
decision), misunderstandings and futility in improving perceptions. This is despite many
organisations being required to have consumer panels, have public meetings, share
materials and the like. The DMAT with some modifications could be an appropriate tool in
the New Zealand setting, along with more work to address responsiveness to Māori
(the indigenous population who have treaty-based specified rights), effective models of
engagement and a prescription for organisations around transparency.
Public participation as the key to acceptable prioritisation
It is generally considered that public participation in prioritising health decisions is an essential
prerequisite for acceptable prioritisation decisions. The Organisation for Economic Cooperation
and Development (Caddy and Vergez, 2001) – in recognising the importance of engaging
citizens in policy making – considers the likely benefits of greater participation to include
increasing the chances of successful implementation of a policy: reinforcing the legitimacy of the
decision-making process and its final results; increasing the chance of voluntary compliance;
and increasing the scope for partnerships with citizens. But evidence demonstrating how
exactly it should be done and how effective it is on a routine basis is lacking (Church et al., 2002;
Ocloo and Mathews, 2016; Bruni et al., 2008; Daniels et al., 2018). Moreover, in practice, what the
public involvement contributes is often under-theorised and may be different for different
instances or stages of decision making. What power does the public hold in their role within the
decision-making exercise? Are they adding further perspectives in order to better inform
decision making without making a decision per se, or are they adding further “votes” in the
decision making itself, so that any given decision reflects an aggregate of varied views?
Despite these concerns public participation in decision making is being encouraged and has
become a key policy in many countries. For example, in the UK, Health Authorities are legally
required to now routinely seek the views of local people and communities in the assessment of
health services and interventions when setting health care priorities. Under the New Zealand
Public Health and Disability Act 2000, national- and district-level agencies are legally required
to have community and public health advisory committees. In Australia, the National Health
and Hospitals Reform Commission has recommended that a systematic mechanism be
developed to formulate health care priorities that incorporate community perspectives as well
as economic and clinical considerations. However, we still have a long way to go translate these
policy aspirations into routine activity in a manner that is efficient and acceptable to the public.
While there are a few evaluations of specific approaches in the UK and New Zealand,
e.g. elected board members (Gauld and Horsburgh, 2014) more methodical and targeted
research on a range of current approaches combined with the development of new and
innovative approaches using novel technology will be the best way forward.
To help address this deficit, we convened a second multidisciplinary workshop in 2016
with delegates from 16 countries and international organisations to identify how the
public are currently engaged with the prioritisation processes in different countries and to








































was published on the conference deliberations. In the introduction, Weale et al. (2016) described
how a mixed-methods approach based on a literature review and a conceptual discussion
revealed the common themes emerging in the field of public participation and health priority
setting. They concentrated on public participation that is collective in character, which is
relevant to whole groups of people and not single individuals. They concluded that the
rationales for public participation can be found in democratic theory, especially as they
relate to the social and political values of legitimacy. They propose in light of the empirical
evidence presented during the workshop that public participatory activities such as protests
and demonstrations should no longer be labelled “unconventional” but should instead be
labelled as “contestatory participation”. This is to better reflect a situation in which these
modes of participation have become more widespread and acceptable in many parts of
the world. In a further conceptual paper, Weale (2016) went on to explore this concept in more
depth and noted that discussions of public participation and priority setting typically
presuppose certain political theories of democracy, and he explored two theories: the
consensual and the agonistic. He took a theoretical reconstruction approach of two ways of
thinking about public participation in relation to priority setting in health care, drawing on
the work of Habermas (1996), a deliberative theorist, and Mouffe, a theorist of agonism
(Laclau and Mouffe, 1985). He concluded that different theoretical approaches can be
associated with different ways of understanding priority setting. These two theories are not
the only theoretical alternatives there is often a merged middle ground. For example, among
deliberative theorists there are competing views about the extent to which mini publics need
to aim at consensus, with some, like Gutmann and Thompson (1996, 2004), urging that
“deliberative theory can be formulated in cases of persistent and deep moral disagreement”.
Similarly, among some agonistic theorists, like Tully (2005, 2008), open deliberation is a way
of dealing with difference. However, the sharply contrasting character of deliberative and
agonist democracy in the work of Habermas (1996) and Mouffe (2005) provides a perspective
that makes it possible to see more clearly how different modes of public participation may
be best theorised. Habermas noted that we cannot expect democracy in health policy to
compensate for the lack of democracy in the political system at large. The third
paper (Slutsky et al., 2016) summarised data from 12 countries, chosen to exhibit wide
variation, on the role and place of public participation in the setting of priorities.
It exhibited cross-national patterns in respect of public participation, linking those differences
to institutional features of the countries concerned. The approach is an example of
case-orientated qualitative assessment of participation. The paper drew on a unique collection
of country case studies in participatory practice in prioritisation, supplementing existing
published sources. In showing that contestatory participation plays an important role in a sub-
set of these countries it has broadened the debate about public participation in priority setting
beyond the use of mini publics and the observation of public representatives on decision-
making bodies’ practices. It concluded that no system has resolved the conceptual
ambiguities that are implicit in the idea of public participation. The fourth paper
(Kieslich, Bump, Norheim, Tantivess and Littlejohns, 2016; Kieslich, Ahn, Badano, Chalkidou,
Cubillos, Hauegen, Henshall, Krubiner, Littlejohns, Lu, Pearson, Rid, Whitty and
Wilson, 2016) offered a different perspective concentrating on one common clinical
therapeutic challenge and assessed how public participation had been approached in four
countries and its effect. New hepatitis C medicines such as Sofosbuvir highlight the complex
and dynamic interaction between the striving for innovation, disputed clinical evidence, budget
impact and fairness in health priority setting. The paper examined the role of public
participation in addressing these considerations. It employed a comparative case study
approach in Brazil, England, South Korea and the USA assessing the differences and
similarities in the coverage decisions about the antiviral Sofosbuvir and how the public and





































issues were the role of the universal right to health in Brazil, the balance between
innovation and overall budget impact in England, the effect of dubious medical practices on
public perception in South Korea and the role and the acceptability and legitimacy
of priority setting processes in the USA. The analysis suggested that public participation
contributes to raising attention to issues that need to be addressed by policymakers.
Public participation activities can thus contribute to setting policy agendas, even if that is
not their explicit purpose. However, whether policymakers see this as a legitimate function
of such groups remains to be seen. The final paper (Hunter et al., 2016) concluded that
challenges emerge as a result of problems of both consensus and contestatory modes of
public involvement in health priority setting. At least two recurring themes emerged.
The first was the importance, but also the challenge, of establishing legitimacy in health
priority setting. The differing country experiences suggest that we understand very little
about the conditions under which differing types of participation generates sufficient
legitimacy to be influential. A second observation was that public participation takes a
variety of forms that depend on the structures in a given national context. Given this variety
the conceptualisation of public participation needs to be expanded to take account of local
culture. The paper concluded that the challenges of public involvement are closely linked to
the question of how legitimate processes and decisions can be generated in priority setting.
This suggests that future research must focus more narrowly on conditions under which
legitimacy is generated in order to expand the understanding of public involvement.
Developing novel ways of stimulating public participation and understanding
One of the main challenges of prioritisation processes which goes to the heart of its legitimacy
is when treatment is withheld from an individual or a group that is considered “needy”.
This type of “case study” is nearly always newsworthy and the system is easily portrayed as
“being unfair” and often triggers an adverse popular response. This is also being reflected in
the examples from Stakeholders in the New Zealand project (Tumilty et al., 2018). What is
missing is the counter argument that highlights that should the “needy” patient be allocated
treatment, then due to the opportunity cost, many more patients would miss out on treatment
and suffer. However, it is difficult to make a “cause celebre” out of these unknown patients.
One potential approach is to take those cases that make the public consciousness but use them
to explore issues in a more subtle thorough way than is usually adopted by the popular press.
This is a way of drawing the public’s attention to the need to prioritise health services fairly in
a manner that makes sense and is relevant to stakeholders, patients and the public. In the UK,
we are exploring the medium of film to explore new ways of interacting with the public. One
author has collaborated with young film makers from the KCL Entrepreneurship Institute to
produce a health prioritisation film relevant to the UK. The film is “The lottery of Devolved
Cancer Care” (www.youtube.com/watch?v=DVhvzr97-ZM) (this is the 20-min version) and
there is 40-min version with more patient interviews (www.youtube.com/watch?v=7dz0
gXw5i64). The film uses variation in access to expensive cancer drugs in the four home
countries of the UK (health care is a devolved responsibility for England, Wales, Scotland and
Northern Ireland). It is based on the circumstances that led a cancer patient Irfon Williams
moving from Wales to England to get his treatment. He established a charity to raise the
issues of differential access to treatment. Irfon died three months after being interviewed and
before he could see the final film but Becky, his widow, said on viewing it, “I think it is
beautifully filmed and thought provoking to those who are outside this bubble of cancer
treatment”. His autobiography was published in May 2018 (www.amazon.co.uk/Fighting-
Chance-Autobiography-Irfon-Williams/dp/1845276779). In the film, he highlights very
specifically that he accepts that not all treatment can be available but considers that a fair
process needs to be in place. If this was the case then he feels that patients, even if they did not








































was not covered at all during the many hours of news coverage of his circumstances and will
be used to raise awareness of the need for public participation in these processes. The film is to
be presented in a series of workshops in England together with the DMAT to explore the
prioritisation issues that are most important to the public. The resulting deliberation will be
assessed by an ethnographer and feed into a new programme to encourage public
participation in local and national health prioritisation processes. We intend to extend this
approach to create a range of country-specific films addressing issues of fairness in health
care prioritisation. Two are already planned for New Zealand and Australia and we are
exploring future films in Thailand and Chile.
Prioritisation as a way to achieve universal health coverage (UHC): the
essential contribution of public participation
While all health care systems are facing rising challenges in creating sustainable health
systems this is particularly so for those countries seeking to implement UHC. Following
endorsement by the World Health Organization (WHA, 2005; WHO, 2010), The World Bank
(2015) and the United Nation’s Sustainable Development Goals (WHO, 2014), the drive
towards UHC is now one of the most prominent global health policies. Addressing the
challenges inherent in such a massive undertaking is involving politicians, academics,
practitioners, patients and members of the public from a myriad of conceptual perspectives.
Despite the multiplicity of approaches, two have emerged to dominate current discourse.
The first is a “rights-based” approach and the second is referred to as “priority setting”.
Protagonists of the first, such as Boaz (Boaz et al., 2014), suggest that this should be the
dominant paradigm. The right to health is enshrined in the United Nations (UN) Declaration
of Human Rights (UN, 1948) and further established in the UN International Covenant on
Social Economic and Cultural Rights (UN, 1966), which defines “the right to the highest
attainable standard of health”. This legally binding Covenant also sets out States Parties
obligations to protect, respect and fulfil the right to health. General Comment (UN, 2002) on
the right to health, while not legally binding, provides robust guidance on the
implementation of the right to health. Boaz argued that a “rights-based” approach to
health (inclusive of health care and the social determinants of health and underpinned by
core principles including accountability, participation and non-discrimination) embraces the
social, political and economic context in which people experience health and all other
approaches should fit into this movement.
The “priorities” approach is underpinned by “HTA” which is defined by the WHO as the
systematic evaluation of properties, effects and/or impacts of health technology. It is a
multidisciplinary process to evaluate the social, economic, organisational and ethical issues
of a health intervention or health technology. The main purpose of conducting an
assessment is to inform a policy decision making. Supporters of this approach argue that,
although at its heart the “rights-based” approach is a noble aspiration, its implementation
can actually lead to a diminution in health (Easterly 2009) when courts are involved
(Mœstad et al., 2011; Norheim and Wilson, 2014) to enforce human rights law. When
countries progress towards UHC, they are forced to make difficult choices about how to
prioritise health issues and expenditure: which services to expand first, whom to include
first and, in effect, who gets treatment and who does not. A further WHO report (WHA,
2005; Chan, 2016) from a rights perspective provides guidance about how countries can
address these issues through three principles that should inform choices on the path to UHC:
first, coverage should be on the basis of need, with extra weight given to the
underprivileged; second, the aim should be to generate the greatest improvement in health;
third, contributions should be based on ability to pay, and not need. However, the report
does not address how a country should fulfil its moral and legal obligations regarding the





































even for countries who have largely achieved UHC. While those most passionate advocates
on both sides consider priority setting and the right to health will always lead to
contradictory policies many now think that they can be made to work together to promote
individual and public health (Rumbold et al., 2017). In a Lancet editorial, the authors
highlight three key factors that would ensure synergy. First, those responsible for advising
on or ensuring a fair allocation of health care resources (e.g. priority setters and local and
national health planners), and those charged with upholding the right to health
(e.g. legislators and judges), need to recognise broader and more recent interpretations of
each approach (Hunt, 2016). Priority setting is not only about a utilitarian drive to maximise
health benefits across the population, nor is the right to health about securing every
individual’s access to health care regardless of cost. Second, when substantive and
procedural principles for ensuring fair allocation of resources devoted to health have been
decided through a transparent and participatory process, states should institutionalise
priority setting. This could include an institution for assessment of new and health
technologies, an advisory committee for wider questions of allocative efficiency and
fairness, and action on the social, economic, and political determinants of health. Such
bodies must be accountable to their populations, the government and the judiciary.
Ensuring the proper functioning of these institutions should be recognised as one way in
which states contribute to the implementation of the right to health. Third, when an
acceptable interpretation of the content of the right to health under national law has been
clarified, finance ministers should review their budgets, considering the state’s obligations
under that right. The right to health, just as civil and political rights, requires resources, to
function whether through taxation or other means. As with civil and political rights, failure
to uphold these rights should result in judicial review.
Practical approaches to getting the public’s view
Time will tell if this guidance gains traction in the international health policy world.
However, whatever their differences, both approaches agree that public participation is key
feature of both governance structures. Yet, while there has been a tremendous drive to
stimulate public participation in making these tough decisions over the last 20 years, it is
apparent that the policy aspiration of public involvement has raced ahead of the
establishment of an evidence base underpinning it (Abelson et al., 2013). Researchers are
now seeking to address this issue (Scuffham et al., 2014) but it seems that the policy-level
debate between a Humanities/Legal and Methodological/Health Economic approach at a
national policy level described in the previous section is also being re-enacted at a
research level in the field of public participation (Boaz et al., 2014; Burton et al., 2014).
In a commentary on an extensive research programme comparing citizen councils and
discrete choice methods to elicit public priorities and preferences in two key areas for health
care – the use of emergency services and management of obesity (Harris et al., 2015, 2018;
Scuffham et al., 2016, 2018; Whitty et al., 2014) – Boaz refers to the argument that
researchers often focus on the hardware of participation (the how to, methods, approaches,
guidelines, etc.) rather than the “software” of values, norms and codes that shape scientific
practice (Wilsdon et al., 2005) and goes onto suggest that all these initiatives should be
viewed from a “rights” perspective. Burton et al. (2014) respond by highlighting that their
research is comparing two frequently used methods of public participation and offers
further evidence of the potential for deliberative events, such as citizen’s juries, to provide
excellent opportunities for “ordinary citizens” to engage in complex health policy debates.
However, they also observe that this is an expensive process and it is difficult to imagine it
being applied on a very wide scale to the full panoply of contemporary health policy
concerns. They suggest that one way forward is to move away from the notion that the








































participation in practice, and a more modest set of questions should be asked every time a
participatory event is planned. These include: who is being invited to join this event and
what is basis of the invitation (expertise, enthusiasm, demographic characteristic or
randomness); what are the terms of engagement (informing, framing, debating and
deciding); and what is the scale of engagement (strategic, programmatic or personal)?
They conclude that, while there is no right answer to any of these questions, having an
answer is especially important for it is known that uncertainty and ambiguity on these
dimensions underpins much of the dissatisfaction in practice with many participatory
events and leads to serious concerns about how “genuine” they are.
Conclusion
Rather than debating whether conceptual or methodological research is required to
address the knowledge gaps, both approaches are needed and should be encouraged. Indeed
the research base should be broadened even further to include the political dimension
(Kieslich, Bump, Norheim, Tantivess and Littlejohns, 2016; Kieslich, Ahn, Badano,
Chalkidou, Cubillos, Hauegen, Henshall, Krubiner, Littlejohns, Lu, Pearson, Rid, Whitty and
Wilson, 2016). We believe that the DMAT, by investigating both process and content values,
provides the pragmatic means of bringing the various stakeholders (including the “rights”
and “priority” approaches) together and can facilitate the dialogue necessary to achieve fair,
efficient and effective health services.
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